Valuation : Tasly Pharmaceutical Group Co., Ltd

Market Cap 2.09TCr 312.21Cr 269Cr 254.71Cr 230.87Cr 433.12Cr 30TCr 435.31Cr 3.03TCr 1.16TCr 15TCr 1.17TCr 1.15TCr 48TCr P/E 2026 *
15.7x
P/E 2027 * 13.2x
Enterprise Value 1.94TCr 289.2Cr 249.17Cr 235.93Cr 213.85Cr 401.19Cr 28TCr 403.23Cr 2.8TCr 1.08TCr 14TCr 1.09TCr 1.06TCr 44TCr EV / Sales 2026 *
2.25x
EV / Sales 2027 * 1.63x
Free-Float
47.11%
Yield 2026 *
2.77%
Yield 2027 * 3.36%
1 day-0.85%
1 week-4.82%
Current month-4.50%
1 month-8.43%
3 months-2.71%
6 months-1.82%
Current year-6.97%
1 week 13.78
Extreme 13.78
14.87
1 month 13.78
Extreme 13.78
15.61
Current year 12.9
Extreme 12.9
16.24
1 year 12.9
Extreme 12.9
16.5
3 years 12.24
Extreme 12.24
18
5 years 9.2
Extreme 9.2
18
10 years 9.2
Extreme 9.2
34.22
Manager TitleAgeSince
Chief Executive Officer 54 08/05/2024
Director of Finance/CFO 49 09/07/2018
Chief Investment Officer 45 01/05/2025
Director TitleAgeSince
Director/Board Member 72 02/06/2021
Chairman 54 10/08/2026
Director/Board Member 58 08/05/2024
Change 5-day change 1-year change 3-year change Capi.($)
-0.85%-4.82%-13.72%+3.39% 312.21Cr
0.00%-1.22%-14.56%-5.64% 1.34TCr
-1.27%-3.07%-33.48%-56.88% 478.37Cr
-0.61%-5.58%-5.83%-6.20% 436.08Cr
-1.49%-4.28%-11.69%-32.46% 378.29Cr
-1.37%-3.98%-25.66%+0.79% 343.03Cr
-2.78%-3.65%-4.32%-5.13% 340.71Cr
-1.30%-2.63%-24.61%-18.99% 227.3Cr
-2.13%-2.81%-29.80%-20.08% 163.42Cr
-1.35%-2.96%-16.64%+13.54% 160.87Cr
Average -1.32%-2.83%-18.03%-12.77% 418.07Cr
Weighted average by Cap. -0.95%-2.28%-16.79%-13.30%

Financials

2026 *2027 *
Net sales 863.35Cr 128.69Cr 110.88Cr 104.99Cr 95Cr 178.53Cr 12TCr 179.43Cr 1.25TCr 479.51Cr 6.25TCr 483.31Cr 472.71Cr 20TCr 935.65Cr 139.47Cr 120.17Cr 113.78Cr 103.13Cr 193.48Cr 13TCr 194.46Cr 1.35TCr 519.66Cr 6.78TCr 523.79Cr 512.3Cr 21TCr
Net income 133.72Cr 20Cr 17Cr 16Cr 15Cr 28Cr 1.9TCr 28Cr 193.13Cr 74Cr 968.78Cr 75Cr 73Cr 3.06TCr 158.03Cr 24Cr 20Cr 19Cr 17Cr 33Cr 2.25TCr 33Cr 228.25Cr 88Cr 1.14TCr 88Cr 87Cr 3.62TCr
Net Debt -154.39Cr -23Cr -20Cr -19Cr -17Cr -32Cr -2.2TCr -32Cr -222.99Cr -86Cr -1.12TCr -86Cr -85Cr -3.53TCr -571.22Cr -85Cr -73Cr -69Cr -63Cr -118.12Cr -8.13TCr -118.72Cr -825.01Cr -317.25Cr -4.14TCr -319.77Cr -312.76Cr -13TCr
Logo Tasly Pharmaceutical Group Co., Ltd
Tasly Pharmaceutical Group Co Ltd is a China-based company principally engaged in the manufacture and distribution of pharmaceutical products. The Company's main businesses include the manufacture and sales of traditional Chinese medicines, chemical preparations, chemical raw materials and biological medicines. The Company's main products include Compound Danshen Dropping Pills, Yangxuenao Granules, Yangxuenao Pills, Qishen Yiqi Dropping Pills, Diqing and Shuilinjia. Its products are used to treat cardiovascular and cerebrovascular diseases, tumors, colds, fevers and liver diseases. The Company mainly distributes its products in the domestic market.
Employees
10,563
Date Price Change Volume
11/26/11 CN¥14.02 -0.85% 2,10,57,925
10/26/10 CN¥14.14 -1.74% 1,09,71,603
09/26/09 CN¥14.39 -1.10% 1,28,17,880
08/26/08 CN¥14.55 -0.48% 1,00,11,300
07/26/07 CN¥14.62 -0.75% 1,10,47,854
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
14.02CNY
Average target price
17.29CNY
Spread / Average Target
+23.32%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 600535 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!